Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study

被引：0
作者：
Linda J Cobiac
Anne Magnus
Jan J Barendregt
Rob Carter
Theo Vos
机构：
[1] University of Queensland,School of Population Health
[2] Deakin University,Deakin Health Economics, Strategic Research Centre – Population Health
来源：
BMC Public Health | / 12卷
关键词：
Absolute Risk; Ischaemic Heart Disease; Pharmaceutical Benefit Scheme; Stroke Event; Cardiovascular Disease Prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 37 条
  • [31] Cost-effectiveness of follow-up invasive coronary angiography after percutaneous coronary stenting: a real-world observational cohort study in Japan
    Shiina, Tetsuya
    Goto-Hirano, Keiko
    Takura, Tomoyuki
    Daida, Hiroyuki
    BMJ OPEN, 2022, 12 (08):
  • [32] Projected impact of change in the percentage of energy from each NOVA group intake on cardiovascular disease mortality in Brazil: a modelling study
    Leitao Moreira, Patricia Vasconcelos
    Pereira de Arruda Neta, Adelia da Costa
    Leite de Lima Ferreira, Flavia Emilia
    de Araujo, Jevuks Matheus
    da Costa Louzada, Maria Laura
    Formiga Cavalcanti de Lima, Rafaela Lira
    de Toledo Vianna, Rodrigo Pinheiro
    da Silva Neto, Jose Moreira
    Colombet, Zoe
    O'Flaherty, Martin
    BMJ OPEN, 2022, 12 (04):
  • [33] Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study
    Sophie Hill
    Janet Spink
    Dominique Cadilhac
    Adrian Edwards
    Caroline Kaufman
    Sophie Rogers
    Rebecca Ryan
    Andrew Tonkin
    BMC Public Health, 10
  • [34] Primary Absolute Cardiovascular Disease Risk and Prevention in Relation to Psychological Distress in the Australian Population: A Nationally Representative Cross-Sectional Study
    Welsh, Jennifer
    Korda, Rosemary J.
    Joshy, Grace
    Banks, Emily
    FRONTIERS IN PUBLIC HEALTH, 2019, 7
  • [35] Legacy of Lipid Lowering in Preventing Fatal and Non Fatal Cardiovascular Events in Individuals Without Cardiovascular Disease During 3 Years of Post Trial Observation in the HOPE 3 (Heart Outcomes Prevention Evaluation) Study
    Bosch, Jackie
    Lonn, Eva M.
    Jung, Hyejung
    Yusuf, Salim
    CIRCULATION RESEARCH, 2019, 125 (12) : E108 - E108
  • [36] Do coronary stent policies affect the cost-effectiveness of percutaneous coronary intervention among patients with acute coronary syndrome in Shanghai? A retrospective cohort study based on real-world and propensity score-matched data
    Lu, Dongzhe
    Shao, Zhenyi
    Wang, Yue
    Xue, Di
    BMJ OPEN, 2024, 14 (06):
  • [37] Cost-effectiveness of adding a non-invasive acoustic rule-out test in the evaluation of patients with symptoms suggestive of coronary artery disease: rationale and design of the prospective, randomised, controlled, parallel-group multicenter FILTER-SCAD trial
    Bjerking, Louise Hougesen
    Hansen, Kim Wadt
    Biering-Sorensen, Tor
    Bronnum-Schou, Jens
    Engblom, Henrik
    Erlinge, David
    Haahr-Pedersen, Sune Ammentorp
    Heitmann, Merete
    Hove, Jens Dahlgaard
    Jensen, Magnus Thorsten
    Kruse, Marie
    Rader, Sune
    Strange, Soren
    Galatius, Soren
    Prescott, Eva Irene Bossano
    BMJ OPEN, 2021, 11 (08):
1234